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Abstract
Seaweed has attracted a great deal of interest as excellent sources of nutrients. Seaweeds 
contain polysaccharides, proteins, amino acids, lipids, peptides, minerals, and some vita-
mins. Polyphenols of seaweed was used as cosmetics and pharmacological as antioxi-
dants, protection from radiation, anti-inflammatory, hypoallergenic, antibacterial, and 
antidiabetic. Besides that seaweed also has a high content of antioxidant that can be used 
to ward off free radicals that increase due to the condition of hyperglycemia in a patient 
with diabetes mellitus. Hence, a great deal of attention has been directed at isolation and 
characterization of seaweed polysaccharides because of their numerous health benefits, 
especially for diabetes mellitus. This paper is expected to provide information on the 
effect of alginate from two seaweeds on blood glucose and lipid profiles of diabetic rats.
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1. Introduction
Diabetes mellitus (DM) is a disease caused by hyperglycemia due to a relative or absolute 
insulin insufficiency. Chronic hyperglycemia can cause complications such as neuropathy, 
retinopathy, nephropathy, and cardiovascular disease [1]. Hyperglycemia can also cause 
impaired balance metabolism of carbohydrates, fats, and proteins [2]. International Diabetes 
Federation (IDF) estimates that in 2013 there were 382 × 106 people with diabetes and 316 × 106 
people suffer from impaired glucose tolerance and increased risk of diabetes. These results 
are expected to increase to 471 × 106 in 2035 and predicted less than 25 years; there would be 
592 × 106 people have diabetes without quick and precise prevention [3].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Seaweeds are the most abundant resources in the ocean. Seaweeds contain polysaccharides, 
proteins, amino acids, lipids, peptides, minerals, and some vitamins. Polyphenols of seaweed 
was used as cosmetics and pharmacological as antioxidants, protection from radiation, anti-
biotics, anti-inflammatory, hypoallergenic, antibacterial, and antidiabetic [4]. Polyphenol 
extracts from seaweed, for example, Alaria, Ascophyllum, Padina, and Palmaria, are able to 
inhibit the activity of α-amylase and α-glucosidase that can lower blood glucose levels [5, 6]. 
On the other hand, seaweed also has a high content of antioxidants that can have beneficial 
value for diabetes mellitus patient [7]. Research on the use of Na alginate from Turbinaria 
ornata and Sargassum crassifolium on in vivo studies in diabetic rats was limited. This paper is 
expected to provide information about the effect of Na alginate from T. ornata and S. crassifo-
lium on the blood glucose and lipid profiles of drug-induced diabetic rats.
2. Extraction of polysaccharides from marine algae
Na alginate from T. ornata and S. crassifolium was extracted as explained by Husni et al. [8, 9]. 
Dried samples were weighted and were soaked in distilled water with the addition of 0.1 N 
HCl to pH 4 for about 24 h 1:15 (w/v). The seaweed was washed with distilled water until 
pH 7. The filtrate was added with 0.5 N Na
2
CO3 (pH 11) 1:10 (w/v) and then heated at 60°C for 2 h. The viscous mixture was added with distilled water 1:10 (w/v) and separated from 
its residue by centrifuge (3500 rpm, 5 min, 4°C) (1 rpm = 1/60 Hz). The Na alginate extract 
was added with 5 N H
2
O
2
 1:4 (v/v), stirred for 30 min before left for two h. The mixture was 
added with 0.5 M CaCl
2
 and stirred for 30 min followed by adding 0.5 N HCl until pH 2. The 
mixture was stirred and left for 30 min at room temperature. Insoluble material (alginic acid) 
was separated from the supernatant by centrifuge. Alginic acid was weighed, was added with 
distilled water and 0.5 N Na
2
CO3 2:2:3 (w/v/v), and was stirred for one h at room temperature to obtain a solid form of Na alginate. Na alginate was precipitated with EtOH slowly 1:1 (v/v) 
and stirred for 30 min, after being centrifuged, followed by drying at 60°C, and the yield of 
alginate was determined.
3. Alginate characterizations (structural and physical properties)
FTIR spectroscopy was used to identify the polysaccharide structures. A pellet of sodium 
alginate was prepared with KBr. FTIR spectrum was recorded on Shimadzu-FTIR Prestige 
21 with a resolution of 4 cm−1 in the 4000–400 cm−1 region, with a scan speed of 0.20 cm s−1. 
The FTIR spectrum of sodium Na alginate of T. ornata showed similar bands to that Na 
alginate standard in 3500–1300 cm−1 region, while the fingerprint region has two bands at 
948.98 cm−1 and 871.82 cm−1 (Figure 1). Sodium alginate of T. ornata showed eight charac-
teristic bands which also could be found in sodium alginate standard (Table 1). According 
to literature, the band at 3400 cm−1 assigned to the hydrogen bonded O-H stretching vibra-
tions and the weak signal at 2931.80 cm−1 due to C-H stretching vibrations [10] and the 
asymmetric stretching of carboxylate O-C-O vibration at 1627.92 cm−1 [10, 11]. The band at 
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1427.32 cm−1 is assigned to C-O-H deformation vibration with the contribution of O-C-O 
symmetric stretching vibration of carboxylate group [10, 12]. The band 1087.85 cm−1 might 
be assigned to C-O and C-C stretching vibrations of pyranose ring [10–12], and the band 
at 1033.85 cm−1 might also be due to C-O stretching vibrations [10]. The anomeric region 
Figure 1. Infrared spectra of Na alginate standard (red) and Na alginate of T. ornata (black).
Wave number (cm−1) Assignments
Na alginate standard [8] Na alginate of T. ornata [8]
3425.58 3464.15 νO–H a
2931.80 2931.80 νC–H a
1620.21 1627.92 ν asym COO- b
1419.61 1427.32 δ C–O–H, νsym COO− (carboxylate ion)1,3
1095.57 1087.85 ν C-O, ν C-C (pyranose ring)1,2,3
1033.85 1033.85 ν C-O1
948.98 948.98 ν C-O (uronic acid residues)1,3
894.97 871.82 δ C1-H (β-mannuronic residues)1,3
1Source: [10].
2[11]
3[12]
Table 1. FTIR spectrum of Na alginate from T. ornata and standard.
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of the fingerprint (950–750 cm−1) showed two characteristic absorption bands. The band at 
948.98 cm−1 was assigned to the C-O stretching vibration of uronic acid residues, and the 
one at 871.82 cm−1 was assigned to the C1-H deformation vibration of β-mannuronic acid 
residues [10, 12].
The peak infrared spectrum of standard alginate and S. crassifolium can be seen in Table 2. 
Based on the FTIR test conducted on alginate extract of S. crassifolium and alginate stan-
dard (Figure 2) on the first band of alginate extract spectra, the vibration frequency of 
779.24 cm−1 shows the residue of guluronic acid. The second band, standard alginate spec-
tra and alginate extracts, contained the same vibration frequency at 948.98 cm−1 showing 
the suspected vibration of C-O stretching as uronic acid. The third band detected vibra-
tions from C-O stretching, wavelengths 1033.85 cm−1 at standard alginate, and 1026.13 cm−1 
on alginate extract. The fourth band in the standard alginate detected vibrations at wave-
lengths of 1095.57 and 1087.85 cm−1 in the extra alginate indicating the presence of OCO 
rings. Symmetrical and asymmetrical C-O vibrations were detected in the standard alginate 
of the fifth and sixth bands indicating the presence of carboxylic groups at 1303.88 and 
1419.61 cm−1 wavelengths, but this vibration was not detected in the alginate extract. The 
seventh band contained a vibration of 2931.8 cm−1 in standard alginates and alginate extracts 
indicating the presence of C-H stretching. O-H is stretching vibration indicating the pres-
ence of H atomic bonds detected in both alginates, 3425.58 cm−1 in standard alginate and 
3471.87 cm−1 in alginate extract.
Wavelength (cm−1) Type of vibration
Na alginate standard [9] Na alginate of S. crassifolium [9] Reference
— 779.24 778.201 Guluronic acid residues
948.98 948.98 950–8102 C-O stretching
1033.85 1026.13 1023.401 C-O stretching
1095.57 1087.85 1100–10503 OCO ring (shoulder)
1303.88 — 1320–12102 C-O stretching
1419.61 — 1460–14002 C-O asymmetric stretching
2931.80 2931.80 ~29252 C-H stretching
3425.58 3471.87 3600–32003 O-H stretching
1Source: [13].
2[14].
3[15].
Table 2. FTIR spectrum of Na alginate from S. crassifolium and standard.
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4. Biological activity of polysaccharides from marine algae
4.1. Effect of Na alginate of T. ornata on body weight of rats
Alloxan-induced diabetic rats did not show a significant decrease in body weight after the 
injection of alloxan. Five groups of diabetic rats had decreased in body weight on 15 days 
treatment, and there were significant differences between the groups of rats. There was no 
significant difference between diabetic control (negative control) compared to positive con-
trol, and the positive control was not significantly different compared to alloxan diabetic rats 
treated with Na alginate 200 mg/kg. Alloxan-induced diabetic rats treated with Na alginate(s) 
(200, 400, 600 mg/kg) did not show significant difference between each other. Administration 
of Na alginate(s) (400, 600 mg/kg) showed a significant difference compared to negative con-
trol. The body weight of alloxan-induced diabetic rats treated with Na alginate 600 mg/kg was 
not significantly different compared to normal control.
The lowering of rats’ body weight treated with alginate from T. ornata showed lower than 
a study conducted by Wikanta et al. [16] using κ-carrageenan and ί-carrageenan. In those 
researches, κ-carrageenan increased the weight by 34.1 g, and ί-carrageenan increased the 
weight by 30.1 g from the body weight on alloxan-induced diabetic rats after 15 days of treat-
ment. The significant reduction in total body weight could be attributed to the loss of fat from 
adipose tissue and catabolism of amino acids in the muscle tissue [17].
Figure 2. Infrared spectra of Na alginate standard (red) and Na alginate of S. crassifolium (black).
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4.2. Effect of Na alginate of S. crassifolium on body weight of rats
Diabetic mice showed weight loss in all treatment groups except the normal control group. 
Normal control group gained weight of 24.1 g. The negative control group had a very signifi-
cant weight loss of 51.6 g. The positive control group had a weight loss of 47.2 g. The treat-
ment group of extract 200 mg/kg had a weight loss of 58.8 g. The treatment group of 400 mg/
kg extract had a weight loss of 45.3 g. Meanwhile, the treatment group giving 600 mg/kg 
extract experienced a decrease in body weight by 43.1 g. Streptozotocin (STZ)-induced dia-
betic rats are one of the animal models of type 1 diabetes mellitus. It is well known for its 
selective pancreatic islet beta-cell cytotoxicity and has been extensively used to induce type 1 
diabetes in an experimental rat model. Glibenclamide is often used as a standard antidiabetic 
drug in STZ-induced diabetes to compare the efficacy of a variety of hypoglycemic drugs [18].
Throughout the experiments, all the rats were monitored daily and/or weekly for the symp-
toms of type 1 diabetes mellitus, including polydipsia, polyuria, polyphagia, hyperglycemia, 
and muscle wasting leading to weight loss and insulin deficiency. Figure 1 shows the observa-
tions of body weight of treated rats during the whole period of experiments. The body weight 
was continuously increased in the normal group and decreased in all diabetes groups. A severe 
loss of body weight characterizes STZ-induced diabetes. Due to absolute or relative deficiency 
of insulin and decrease of the production of ATP, protein synthesis decreases in all tissues.
5. Effect of Na alginate on blood glucose
Alloxan is a urea derivative which causes selective necrosis of the pancreatic islet β-cells [19]. 
Alloxan and its reduction product dialuric acid establish a redox cycle with the formation 
of superoxide radicals [20]. Preprandial blood glucose levels were determined as fasting 
blood glucose. Fasting is defined as no calorie intake for at least 8 h [1]. Diabetes is diagnosed 
when the fasting plasma glucose concentration is consistently ≥7 mmol/L (126 mg/dL) or 
when the 2 h plasma glucose concentration (after drinking a 75 g glucose load) is consistently 
≥11.1 mmol/L (200 mg/dL) [21].
Administration of alloxan led to a significant increase of preprandial blood glucose levels 
in rats after 3 days. Administration of Na alginate(s) (200, 400, 400 mg/kg) significantly 
reduced the blood glucose level compared to diabetic control. The dose of 200 and 400 mg/
kg of Na alginate did not show a significant difference compared to normal control and 
positive control (Table 3). The result was supported by previous studies using fiber to 
decrease preprandial blood glucose. Nelson et al. [22] used high indigestible fiber and low 
indigestible fiber diet to decrease preprandial blood glucose in diabetic dogs for 8 months 
which resulted in high indigestible fiber significantly that reduces preprandial blood glu-
cose better than low indigestible fiber. Nelson et al. [23] used similar treatment in diabetic 
cats for 24 weeks and showed high indigestible fiber which gave a better effect on decreas-
ing preprandial blood glucose than low indigestible fiber. Chandalia et al. [12] compared 
the amount of fiber that was given to diabetic patients according to the American Diet 
Seaweed Biomaterials32
Association (8 g digestible fiber and 16 indigestible fiber) and fiber-rich diet (25 g digestible 
fiber and 25 indigestible fiber) for 6 weeks. Fiber-rich diet decreased 13% preprandial blood 
glucose lower than ADA diet.
Normal postprandial blood glucose level is <180 mg/dL [1]. In the normal state, the postpran-
dial blood glucose level increases less than 50 mg/dL from the preprandial blood glucose 
level after carbohydrate intake [24]. Alloxan-induced diabetic rats’ postprandial blood glu-
cose level surpassed 200 mg/dL after 3 days of injection. After 15 days of treatment, the result 
was the administration of Na alginate(s) (200, 400, 600 mg/kg) which significantly reduces 
postprandial blood glucose levels on rats compared to diabetic control (P < 0.05). However, it 
failed to restore the level to that of normal control group and positive control group (P < 0.05). 
The positive control group could restore the postprandial blood glucose level at the same 
level as a normal control group (Table 4).
Wolf et al. [25] used 1.5 g sodium alginate to show its effect on postprandial glucose peak and 
glucose uptake reduction after 3 h which resulted in line 32.80 ± 3.40 and 1429 ± 276 mg/dL. 
Sodium alginate had a reduction effect better than 1.2 g gum arabic and 0.3 g gum guar with 
postprandial glucose peak 40.40 ± 3.30 mg/dL and glucose uptake 1717 ± 433 mg/dL. A study 
on the effect of a meal containing alginate compared to testing a meal without alginate by 
Torsdottir et al. [26] showed that postprandial blood glucose levels by meal containing algi-
nate decrease 31% lower than a meal without alginate.
Preprandial glucose levels for all treatment groups of alginate from S. crassifolium were clas-
sified into normal levels ranging from 69.311 to 88.029 mg/dL and no significant difference. 
The streptozotocin-induced treatment group experienced very high preprandial glucose lev-
els exceeding 200 mg/dL and can be categorized as DM. The same is also shown in Moree 
et al. [27]. In this study, male Wistar rats induced by streptozotocin dose 60 mg/kg increased 
blood glucose levels <200 mg/dL. The use of 60 mg/kg of streptozotocin in mice can trigger an 
autoimmune process that can produce damage to the Langerhans island beta cells [28]. Also, 
Group Preprandial blood glucose (mg/dL)*
T. ornata [8] S. crassifolium [9]
Normal control 106.06 ± 11.33b,c 126.30 ± 0.50a
Negative control 208.57 ± 70.60a 568.82 ± 46.40c
Positive control 86.29 ± 13.83b 316.35 ± 20.90b
Alginate (200 mg/kg) 108.50 ± 11.28c 279.45 ± 92.50b
Alginate (400 mg/kg) 96.55 ± 15.65b,c 336.63 ± 66.32b
Alginate (600 mg/kg) 99.03 ± 14.26b,c 257.66 ± 34.61b
*Values are means ± SD. Values followed by the different superscript symbol(s) in each column were significantly 
different (P<0.05).
Table 3. Effect of Na alginate of T. ornata and S. crassifolium on preprandial blood glucose in alloxan-induced diabetic 
rats.
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STZ is also capable of generating reactive oxygen that has a high role in the destruction of 
pancreatic β-cells and eventually occurs inhibition of insulin secretion and synthesis resulting 
in hyperglycemia [29].
All treatment groups of extracts of S. crassifolium did not differ significantly with the positive 
control (Table 3). It can be concluded that all three doses of administration of the extract of S. 
crassifolium had the same effect as the positive control group in lowering blood glucose levels 
in mice suffering from DM. The opposite is shown in the negative control treatment group 
that has a prepreg glucose level that increases from day to day due to accumulated glucose 
buried in the blood without treatment efforts.
In general, the viscosity of dietary fiber can reduce the rise in blood glucose levels and reduce 
food intake by slowing the empty stomach and slowing the absorption of nutrients in the 
small intestine. Based on these two mechanisms, it is still not clear what mechanisms apply 
to sodium alginate, perhaps one or both [30]. Different doses of alginate will affect the viscos-
ity of the given test preparation. So, it will lead to differences in the viscosity of the fluid in 
the gastrointestinal tract and ultimately result in differences in the rate of glucose absorption 
from the gastrointestinal tract into the blood vessels [31].
6. Total cholesterol
Diabetes is associated with major abnormalities in fatty acid metabolism. The resulting distur-
bance results in an abnormal lipoprotein cascade from the large chylomicron through to the 
small HDL particle [31, 32]. Total cholesterol in the serum of negative control was not signifi-
cantly different compared to positive control, Na alginate 200 and 400 mg/kg treatment, and 
normal control. Na alginate 600 mg/kg of T. ornata was a significant difference compared to 
negative control (P < 0.05). The alginate dose of 200 and 600 mg/kg of T. ornata did not show 
the difference (P > 0.05) (Table 5) significantly.
Group Postprandial blood glucose (mg/dL)*
T. ornata [8] S. crassifolium [9]
Normal control 133.05 ± 15.81b 150.416 ± 5.1a
Negative control 360.48 ± 40.80a 633.470 ± 27.8c
Positive control 140.75 ± 9.16b 333.814 ± 64.5ab
Alginate (200 mg/kg) 257.08 ± 34.20c 421.652 ± 21.4bc
Alginate (400 mg/kg) 238.61 ± 21.48c 433.333 ± 21.8bc
Alginate (600 mg/kg) 196.05 ± 18.22d 381.250 ± 11.4ab
*Values are means ± SD. Values followed by the different superscript symbol(s) in each column were significantly 
different (P<0.05).
Table 4. Effect of Na alginate of T. ornata and S. crassifolium on postprandial blood glucose in alloxan-induced diabetic 
rats.
Seaweed Biomaterials34
Several previous studies supported the result. Suzuki et al. [33] evaluated the effect of algi-
nate-rich guluronic and mannuronic on cholesterol levels in rats fed with diets containing 
both alginates and cholesterol which resulted from reductions in liver cholesterol in rats fed 
with each alginate and significantly low cholesterol accumulation in mannuronic acid-rich 
alginate. Ren et al. [34] screened 26 species of seaweeds and six polysaccharides from algae 
to study their effect on lipid in rats fed with basal diet for 28 days of treatment. The six 
polysaccharides were sulfated glucuronoxylomannan (0.5%), fucoidin (1%), sodium alginate 
(1%), funorin (2.5%), porphyrin (2.5%), and agar (2.5%). Reduction effect of each polysac-
charide was 64, 65, 68, 77, 88, and 95%, respectively, compared to control group. At the end 
of the study, the polysaccharides could restore the cholesterol level to the same level as the 
control group.
Total cholesterol levels of the normal control group, positive control, and alginate 600 mg/kg 
of S. crassifolium had a significant difference compared to the negative control group (Table 5). 
The three treatment groups had lower cholesterol levels than the negative control group. An 
extract at a dose of 600 mg/kg of S. crassifolium can lower total cholesterol levels as well as 
positive controls (glibenclamide). The opposite is shown by the treatment group giving the 
extract dose of 200 and 400 mg/kg of S. crassifolium. Both the doses are less effective in lower-
ing total cholesterol levels in mice suffering from diabetes compared to glibenclamide and 
alginate 600 mg/kg of S. crassifolium.
Wikanta et al. [35] reported that sodium alginate could lower total cholesterol in mice with 
hypercholesterolemia. Administration of sodium alginate with a viscosity of 450 cps signif-
icantly reduced total cholesterol levels compared to sodium alginate with lower viscosity. 
Because, sodium alginate is a water-soluble fiber compound, forming a viscous solution. The 
stomach fluid cannot digest this compound in the gastrointestinal tract. When dissolved in 
water, the sodium alginate fibers form a mesh-like grid that strongly binds many water mol-
ecules in a well-defended solute. Its properties as emulgator increasingly enhance the binding 
ability. A similar mechanism occurs against lipid molecules in bile acids in the gastrointesti-
nal tract. The binding or bonding of lipids by the alginate makes lipid and cholesterol unable 
Group Total cholesterol (mg/dL)*
T. ornata [8] S. crassifolium [9]
Normal control 70.40 ± 7.12b 41.55 ± 0.20a
Negative control 67.75 ± 16.02b 68.41 ± 12.50b
Positive control 72.40 ± 15.24b 45.79 ± 9.80a
Alginate (200 mg/kg) 55.80 ± 3.42a,b 49.05 ± 20.00ab
Alginate (400 mg/kg) 65.60 ± 14.47b 54.46 ± 11.00ab
Alginate (600 mg/kg) 47.80 ± 5.40a 34.20 ± 7.50a
*Values are means ± SD. Values followed by the different superscript symbol(s) in each column were significantly 
different (P<0.05).
Table 5. Effect of Na alginate of T. ornata and S. crassifolium on the total cholesterol in alloxan-induced diabetic rats.
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to absorb the body through the small intestine so that it eventually comes out with the stool. 
Suzuki et al. [33] also reported that alginate with various mannuronic acid and guluronic acid 
compositions can decrease total blood cholesterol levels.
7. HDL-c
Administration of Na alginate to alloxan-induced diabetic rats for 200 mg/kg alginate of 
T. ornata did not show significant differences compared to negative control and positive con-
trol (P > 0.05) (Table 6). The alginate of T. ornata at a dose of 200 and 400 mg/kg was not sig-
nificantly different between each other. All of the various doses of alginate were significantly 
different compared to normal control (P < 0.05). HDL-c management on type 2 diabetes is 
targeting for >40 mg/dL (>50 mg/dL on female) [1]. HDL particles seem to have antioxidant 
properties, inhibiting the oxidation of LDL cholesterol and the expression of cellular adhe-
sion molecules and monocyte recruitment. The HDL may also reduce the risk of thrombosis 
by inhibiting platelet activation and aggregation [33]. Ren et al. [34] reported that three algal 
species showed the ability to increase HDL-c levels in blood serum of rats. Fucoidan could 
increase HDL-c levels up to 47% compared to the control group. Five other polysaccharides, 
sulfated glucuronoxylorhamman, sodium alginate, funoran, porphyran, and agar, found 
increased HDL-c by 31.97, 28.93, 9.14, 3.55, and 26.90%, respectively.
According to Rohman [36] HDL is a protective lipoprotein, in addition to functioning to bring 
fat to the liver; HDL proved to inhibit the oxidation of LDL and adhesion molecules. HDL-c 
levels throughout the treatment group did not have a significant difference. The same is also 
shown in the study of Suzuki et al. [33] that there was no statistically significant difference 
in HDL-c levels in mice suffering from hypercholesterolemia treated with sodium alginate in 
comparison with different glucuronic acid and mannuronic acids.
Group HDL-c (mg/dL)*
T. ornata [8] S. crassifolium [9]
Normal control 108.00 ± 6.59c 70.549 ± 1.50a
Negative control 59.75 ± 9.39a 75.549 ± 11.10a
Positive control 58.00 ± 7.78a 96.843 ± 14.10a
Alginate (200 mg/kg) 61.80 ± 5.57a 97.617 ± 11.50a
Alginate (400 mg/kg) 74.80 ± 10.08b 84.03 ± 28.20a
Alginate (600 mg/kg) 78.60 ± 10.60b 75.98 ± 17.70a
*Values are means ± SD. Values followed by the different superscript symbol(s) in each column were significantly 
different (P<0.05).
Table 6. Effect of Na alginate of T. ornata and S. crassifolium on HDL-c in alloxan-induced diabetic rats.
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8. LDL-c
LDL-c after administration of alginate(s) from T. ornata (200, 400, 600 mg/kg) was not 
significantly different between each other. Alginate of T. ornata 600 mg/kg showed a 
significant difference compared to negative control, positive control, and normal control 
group (Table 7). Ren et al. [34] studied the effect of polysaccharide extracts from algae 
on LDL-c in blood serums of rats given with basal diet for 28 days. The six polysaccha-
rides used in the study decreased LDL-c levels in blood serum. Sodium alginate (1%) 
decreased 34.04% of LDL-c. Five other polysaccharides, sulfated glucuronoxylorham-
man, sodium alginate, funoran, porphyran, and agar, decreased the LDL-c in line with 
36.42, 37.66, 24.33, 36, and 14%, respectively, compared to normal control. LDL is not 
usually increased in diabetes. In part, this may represent a balance of factors that affect 
LDL production and catabolism. A necessary step in LDL production is hydrolysis of its 
precursor VLDL by LpL. A reduction can happen in this step because LpL deficiency or 
excess surface apoproteins (C1, C3, or possibly E) decreases LDL synthesis. Conversely, 
increases in this lipolytic step that accompany weight loss, fibric acid drug therapy, and 
treatment of diabetes may increase LDL levels. In diabetes, a reduction in LDL produc-
tion may be counterbalanced by decreases in LDL receptors and/or the affinity of LDL 
for those receptors [37].
Administration of sodium alginate from S. crassifolium most effective in lowering LDL-c levels 
near the control group was 600 mg/kg followed by 200 mg/kg and 400 mg/kg. The negative 
control group had a very significant difference with all the other treatment groups (Table 7). 
The negative control group had higher LDL-c levels when compared to the other treat-
ment groups. Meanwhile, the positive control group had lower LDL-c levels than the other 
Group LDL-c (mg/dL)*
T. ornata [8] S. crassifolium [9]
Normal control 58.80 ± 7.19a 34.07 ± 0.90a
Negative control 60.75 ± 16.52a 55.34 ± 8.30b
Positive control 65.00 ± 14.05a 27.51 ± 10.00a
Alginate (200 mg/kg) 49.60 ± 3.13a,b 31.81 ± 11.80a
Alginate (400 mg/kg) 55.60 ± 13.13a,b 33.91 ± 5.30a
Alginate (600 mg/kg) 41.00 ± 5.83b 28.78 ± 5.30a
*Values are means ± SD. Values followed by the different superscript symbol(s) in each column were significantly 
different (P<0.05).
Table 7. Effect of Na alginate of T. ornata and S. crassifolium on LDL-c in alloxan-induced diabetic rats.
Therapeutic Potential of Seaweed Polysaccharides for Diabetes Mellitus
http://dx.doi.org/10.5772/intechopen.76570
37
treatment groups. Levels of LDL-c in this study are still within normal limits, i.e., <130 mg/
dL, and Rachmat and Rasyid [38] reported that mice were given 50 and 250 g of alginates of 
S. crassifolium which also did not affect LDL-c levels.
9. Triglyceride
Triglyceride management on type 2 diabetes is targeting for <150 mg/dL [1]. When the glu-
cose levels excess in the blood, glucose will be converted to triglycerides in which triacylglyc-
erol synthesis process is known as lipogenesis. Carbohydrate-rich meal can lead to increase 
the process of lipogenesis in the liver and adipose tissue. However, the occurrence of insu-
lin resistance inhibits lipogenesis process making glucose and free fatty acid levels in blood 
plasma increased. In the liver, triglyceride accumulation can cause malfunctioning of the 
liver (fatty liver) or liver cirrhosis in the long term [39]. Triglyceride of alloxan-induced dia-
betic rats did not show a significant difference between the groups of treatment using algi-
nate of T. ornata. The triglyceride levels remained at normal levels through the given time of 
the study (Table 8).
Paxman et al. [40] reported that a drink containing alginate in the obese patient had no effect 
on tryglyceride level. Triglyceride levels did not show a significant difference between algi-
nate treatment group and control group. Ren et al. [34] used six polysaccharides from algal 
species as a treatment for rats given with basal diet for 28 days. All of the polysaccharides 
used in this research could reduce triglyceride levels as good as their ability reducing LDL-c 
in blood serum. Funoran and sulfated glucuronoxylorhamman reduced triglyceride levels 
between 46 and 64% compared to the control group. Sodium alginate could decrease the 
Group Triglyceride (mg/dL)*
T. ornata [8] S. crassifolium [9]
Normal control 75.80 ± 10.33a 28.73 ± 12.20a
Negative control 77.75 ± 20.90a 77.73 ± 14.10b
Positive control 80.40 ± 13.14a 24.31 ± 9.60a
Alginate (200 mg/kg) 63.40 ± 25.41a 24.12 ± 17.70a
Alginate (400 mg/kg) 60.80 ± 13.80a 31.73 ± 2.90a
Alginate (600 mg/kg) 54.80 ± 10.91a 37.67 ± 8.50a
*Values are means ± SD. Values followed by the different superscript symbol(s) in each column were significantly 
different (P<0.05).
Table 8. Effect of Na alginate of T. ornata and S. crassifolium on the triglyceride in alloxan-induced diabetic rats.
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triglyceride level to 29% compared to the control group. Fucoidan can reduce the triglyceride 
levels to 12–20% [34].
The levels of triglycerides during the experiment using alginate of S. crassifolium were 
decreased. The negative control treatment group had a significant difference when compared 
to all treatment groups (Table 8). This suggests that the three doses of alginate from S. crassi-
folium can lower triglyceride levels equally well with the positive control group that is close to 
the triglyceride levels of the normal control group.
All groups treated with DM except for the normal control group showed elevated triglycer-
ide levels. Levels of triglycerides increased up to 574.867 mg/dL. The condition of hypertri-
glyceridemia can be diagnosed if the triglyceride level >150 mg/dL [41]. According to Pujar 
et al. [42], this can be due to direct damage from the pancreatic tissue by high free fatty acids. 
The concentration of high free fatty acid will decrease the pH and may activate trypsinogen. 
Also, high triglyceride levels can also be caused by the destruction of chylomicron which 
is a triglyceride carrier. This changes the acinar function and opens the pancreatic tissue to 
triglycerides.
10. Necrosis of pancreas
Necrosis is defined as the type of cell death caused by changing the morphology of the 
nucleus, including chromatin condensation and fragmentation, minor changes in cytoplas-
mic organelles, and overall causes of cell shrinkage (apoptosis) and autophagic accumulation 
of two vacuole membranes in the cytoplasm [43]. In type I diabetes mellitus, patients found 
changes in the pancreas in the form of the reduced size of the pancreas, atrophy in the exo-
crine pancreas, and atrophy of the acinar cells around the degenerated Langerhans island. On 
the other hand, in type II diabetes mellitus, an imbalance of exocrine secretion of the pancreas 
and impaired control of blood glucose occur [44].
Normal controls show normal cell conditions (Figure 3). Negative controls show some dam-
age to the cell. The positive control treatment group also shows the same. The treatment 
group of sodium alginate extract is entirely damaged in cells (necrosis). The treatment group 
of S. crassifolium dose of alginate at 200 and 400 mg/kg had more damage than the treatment 
group of 600 mg/kg alginate. The results of the histological analysis showed that all treat-
ment groups experienced cell damage (necrosis) except the normal control group. According 
to Holemans et al. [45], streptozotocin prevents DNA synthesis in mammals and bacterial 
cells. In bacterial cells, it provides a special reaction with the cytosine group that causes 
degeneration and destruction of DNA. This biochemical reaction in mammals causes cell 
death. Damage to cells in the islets of Langerhans island cells caused by streptozotocin is 
irreversible. Similar results were also shown in a study conducted by Elias et al. [46] and 
Ikebukuro et al. [47].
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11. Conclusion
Administration of alginate from T. ornata in alloxan-induced diabetic rats decreased the pre-
prandial and postprandial blood glucose, lowered total cholesterol, increased HDL-c, and low-
ered LDL-c in dependent dose manner. However, sodium alginate of T. ornata did not show any 
Figure 3. Histological studies of STZ diabetic rat pancreas. Normal control: pancreatic section showed the normal size of 
islets, and destruction was absent (Grade -). Negative control: pancreatic section showed (green arrow) occasional islets, 
and (orange arrow) destruction was severe (Grade ++++). Positive control (diabetic rats +5 mg glibenclamide/kg b.w.): 
pancreatic section showed moderate islet architecture (green arrow), and destruction (orange arrow) was moderate 
(Grade +++). Diabetic rats +200 mg alginate/kg b.w., and diabetic rats 400 mg alginate/kg b.w.: pancreatic section 
showed (green arrow) occasional islets, and (orange arrow) destruction was severe (Grade ++++). Diabetic rats +600 mg 
alginate/kg b.w.: pancreatic section showed (green arrow) additive improvement in the mass of islets as compared to 
other alginate treatments, and (orange arrow) destructions was mild (Grade ++). Grade −, normal; Grade ++++, severe 
destruction; Grade +++, moderate destruction; Grade ++, mild injury.
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effect on triglyceride. This result can be valuable information to discover alternative therapy 
to achieve and/or maintain glycemic control and lipid profile management on diabetes patient. 
Nevertheless, the possibility warrants further confirmation. On the other hand, the present 
study shows that the alginate S. crassifolium has potential antidiabetic action in STZ-induced 
diabetic rats and the effect was found to be more similar to the reference drug glibenclamide.
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